English

Research and Development

SSI is one of Denmark’s largest research institutions in the health sector.
More about SSI's research and development

R and DSSI is one of Denmark’s largest research institutions in the health sector
ProductsVaccines, In vitro diagnostics
Contract ServicesSSI provides contract work within our core activities and competences
Job and CareerRead about SSI as a workplace and meet some of our employees
To hænder - barn og voksen

SSI and the global community

In 2010 SSI signed the UN Global Compact. Now SSIs first report on corporate social responsibility is available. Read more about SSIs work on Corporate Social Responsibility...
SSI Diagnostica products

Order your in vitro diagnostic products online

SSI Diagnostica offers the opportunity for our direct customers to order in vitro diagnostic products online. Click here to visit the webshop…
06-02-2012
In 2011, a total of 150 persons were given post-exposure treatment against rabies following animal bites.
06-02-2012
Recently, a status meeting was held covering the inundations following the Copenhagen rainstorm which occurred on 2 July 2011.
01-02-2012
In 2010 SSI signed the UN Global Compact and thereby concurred in its ten principles of human rights, wage-earner rights, envir...
30-01-2012
Hantavirus is transmitted to humans from rodents, primarily through inhalation of atomized urine and faeces, but also via bites...

More news...

Rabies 2011
-Rabies prophylaxis
-Rabies in animals
Theme day: Copenhagen rainstorm 2 July 2011
Hantavirus 2010-2011
Outbreak of salmonella Strathcona
EPIET
Shigellosis 2008-2010
Conjugate pneumococcal vaccine approved for use in adults above 50 yearsEurosurveillance fifteen year anniversary 1996-2011...
Infectious diseases 2011

More EPI-NEWS...

10-02-2012
An international scientific study including Danish scientists, published this week in Journal of the National Cancer Institute, conf...
26-01-2012
It has long been known that ethnic Europeans have a much higher risk of dying from serious malaria infection than ethnic Africans. Ne...
11-01-2012
The combination of SSI’s novel tuberculosis subunit vaccine candidate and Intercell’s proprietary IC31® adjuvant enters Phase II clin...
20-12-2011
In a nationwide Danish study published in the international journal ‘Gut’, researchers from Statens Serum Institut report that women...

More R and D News...

Available Positions:

Currently, we have no available positions.